Squaramides are a class of extremely versatile receptors for anion recognition, sensing, transport and extraction.

Ion channels and transporters typically consist of biomolecules that play key roles in a large variety of physiological and pathological processes. Traditional therapies include many ion-channel blockers, and some activators, although the exact biochemical pathways and mechanisms that regulate ion homeostasis are yet to be fully elucidated. An emerging area of research with great innovative potential in biomedicine pertains the design and development of synthetic ion channels and transporters, which may provide unexplored therapeutic opportunities. However, most studies in this challenging and multidisciplinary area are still at a fundamental level. In this review, we discuss the progress that has been made over the last five years on ion channels and transporters, touching upon biomolecules and synthetic supramolecules that are relevant to biological use. We conclude with the identification of therapeutic opportunities for future exploration.

Three novel bis-urea fluorescent low-molecular-weight gelators (LMWGs) based on the tetraethyl diphenylmethane spacer—namely, L1, L2, and L3, bearing indole, dansyl, and quinoline units as fluorogenic fragments, respectively, are able to form gel in different solvents. L2 and L3 gel in apolar solvents such as chlorobenzene and nitrobenzene. Gelator L1 is able to gel in the polar solvent mixture DMSO/H₂O (H₂O 15% v/v). This allowed the study of gel formation in the presence of anions as a third component. An interesting anion-dependent gel formation was observed with fluoride and benzoate inhibiting the gelation process and H₂PO₄⁻, thus causing a delay of 24 h in the gel formation. The interaction of L1 with the anions in solution was clarified by ¹H-NMR titrations and the differences in the cooperativity of the two types of NH H-bond donor groups (one indole NH and two urea NHs) on L1 when binding BzO⁻ or H₂PO₄⁻ were taken into account to explain the inhibition of the gelation in the presence of BzO⁻. DFT calculations corroborate this hypothesis and, more importantly, demonstrate considering a trimeric model of the L1 gel that BzO⁻ favours its disruption into monomers inhibiting the gel formation.

Here, two new fluorescent squaramides bearing quinoline (L1) and naphthalene (L2) as fluorogenic fragments were synthesized and investigated as possible cellular imaging probes. Results showed that L1 is able to pass through the cell membranes of living tumoral (Caco-2) and non-tumoral (293T) human cell lines, while L2 interacts with the cell membranes but does not enter the tested cells. In addition, L1 and L2 were loaded in monoolein-based cubosomes, and also such fluorescent formulations were successfully used for cellular imaging, showing that in vivo application can be conceived for this kind of imaging probes.

Bis-squaramide receptors L1–L4 bearing a dansyl moiety were considered as fluorescent probes for non steroidal antinflamatory drugs naproxene and ketoprofen.

The new symmetric acyclic N,N’-bis(1-pyrenyl) squaramide (H₂L) functionalized with the pyrene moiety as a fluorogenic fragment has been designed and its ability to selectively detect specific anions and metals investigated. H₂L selectively binds Cl⁻ both in solution (DMSO 0.5% H₂O and MeCN) and in the solid state, and allows to selectively detect Cu²⁺ in MeCN with the formation of a 2:1 metal-receptor complex, with a green intense emission appreciable by naked eye under the UV lamp. The H₂L copper complex preserves its emission properties in the presence of Cl⁻. The addition of basic anions (OH⁻, CN⁻, and F⁻) up to 10 equivalents caused the deprotonation of the squaramide NHs and a dramatic change of the emission properties of the H₂L copper complex.